CompletedNot Applicable

Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure

Germany85 participantsStarted 2015-11

Plain-language summary

The investigators compared the feasibility of serum creatine kinase and serum lactate concentration as diagnostic markers to distinguish between generalized tonic-clonic seizures (GTCS) and syncopes in clinical settings that require fast-action treatment, such as in the emergency departments.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with generalized tonic-clonic seizures and syncopes and whose blood samples were taken within 2 hours after the event 18 years or older Observed seizure Time of the event before admission was known Diagnosis of an epileptic seizure or syncope had been entered in the final discharge report Exclusion Criteria: Prisoner Age \< 18 years old Competing explanations for serum lactate or CK elevation e.g. shock or trauma Lack of capacity for consent

What they're measuring

Comparison of the first measurements of serum lactate and creatine kinase concentrations in blood samples between patients admitted with either a generalized tonic-clonic seizure or a syncope

Timeframe: 2 hours

Trial details

NCT IDNCT02926703

SponsorRWTH Aachen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-08

View on ClinicalTrials.gov More Seizure trials